9-14842660-C-G

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001379081.2(FREM1):​c.1394G>C​(p.Gly465Ala) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0127 in 1,610,642 control chromosomes in the GnomAD database, including 298 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.012 ( 24 hom., cov: 33)
Exomes 𝑓: 0.013 ( 274 hom. )

Consequence

FREM1
NM_001379081.2 missense, splice_region

Scores

2
9
8
Splicing: ADA: 0.7675
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 4.69

Publications

13 publications found
Variant links:
Genes affected
FREM1 (HGNC:23399): (FRAS1 related extracellular matrix 1) This gene encodes a basement membrane protein that may play a role in craniofacial and renal development. Mutations in this gene have been associated with bifid nose with or without anorectal and renal anomalies. Alternatively spliced transcript variants encoding different isoforms have been described. PubMed ID 19940113 describes one such variant that initiates transcription within a distinct, internal exon; the resulting shorter isoform (named Toll-like/interleukin-1 receptor regulator, TILRR) is suggested to be a co-receptor of the interleukin 1 receptor family and may regulate receptor function and Toll-like receptor/interleukin 1 receptor signal transduction, contributing to the control of inflammatory response activation. [provided by RefSeq, Apr 2011]
FREM1 Gene-Disease associations (from GenCC):
  • oculotrichoanal syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • BNAR syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • isolated trigonocephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • renal agenesis, unilateral
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • trigonocephaly 2
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007178992).
BP6
Variant 9-14842660-C-G is Benign according to our data. Variant chr9-14842660-C-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 218939.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.012 (1829/152294) while in subpopulation SAS AF = 0.0435 (210/4830). AF 95% confidence interval is 0.0387. There are 24 homozygotes in GnomAd4. There are 947 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 24 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FREM1NM_001379081.2 linkc.1394G>C p.Gly465Ala missense_variant, splice_region_variant Exon 9 of 37 ENST00000380880.4 NP_001366010.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FREM1ENST00000380880.4 linkc.1394G>C p.Gly465Ala missense_variant, splice_region_variant Exon 9 of 37 5 NM_001379081.2 ENSP00000370262.3 Q5H8C1-1
FREM1ENST00000380875.7 linkn.1394G>C splice_region_variant, non_coding_transcript_exon_variant Exon 10 of 31 1 ENSP00000370257.3 F8WE85

Frequencies

GnomAD3 genomes
AF:
0.0119
AC:
1817
AN:
152176
Hom.:
19
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0109
Gnomad AMI
AF:
0.0505
Gnomad AMR
AF:
0.0192
Gnomad ASJ
AF:
0.00259
Gnomad EAS
AF:
0.0189
Gnomad SAS
AF:
0.0443
Gnomad FIN
AF:
0.000659
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.00953
Gnomad OTH
AF:
0.0196
GnomAD2 exomes
AF:
0.0191
AC:
4667
AN:
244410
AF XY:
0.0196
show subpopulations
Gnomad AFR exome
AF:
0.0108
Gnomad AMR exome
AF:
0.0425
Gnomad ASJ exome
AF:
0.00202
Gnomad EAS exome
AF:
0.0181
Gnomad FIN exome
AF:
0.000914
Gnomad NFE exome
AF:
0.00981
Gnomad OTH exome
AF:
0.0177
GnomAD4 exome
AF:
0.0128
AC:
18629
AN:
1458348
Hom.:
274
Cov.:
31
AF XY:
0.0137
AC XY:
9945
AN XY:
725328
show subpopulations
African (AFR)
AF:
0.0119
AC:
399
AN:
33438
American (AMR)
AF:
0.0401
AC:
1793
AN:
44680
Ashkenazi Jewish (ASJ)
AF:
0.00208
AC:
54
AN:
26022
East Asian (EAS)
AF:
0.0165
AC:
656
AN:
39680
South Asian (SAS)
AF:
0.0475
AC:
4082
AN:
86016
European-Finnish (FIN)
AF:
0.000985
AC:
52
AN:
52806
Middle Eastern (MID)
AF:
0.0290
AC:
164
AN:
5646
European-Non Finnish (NFE)
AF:
0.00949
AC:
10528
AN:
1109800
Other (OTH)
AF:
0.0150
AC:
901
AN:
60260
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
895
1790
2686
3581
4476
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
460
920
1380
1840
2300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0120
AC:
1829
AN:
152294
Hom.:
24
Cov.:
33
AF XY:
0.0127
AC XY:
947
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.0109
AC:
455
AN:
41558
American (AMR)
AF:
0.0192
AC:
294
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00259
AC:
9
AN:
3470
East Asian (EAS)
AF:
0.0187
AC:
97
AN:
5186
South Asian (SAS)
AF:
0.0435
AC:
210
AN:
4830
European-Finnish (FIN)
AF:
0.000659
AC:
7
AN:
10618
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.00953
AC:
648
AN:
68016
Other (OTH)
AF:
0.0265
AC:
56
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
90
179
269
358
448
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0120
Hom.:
60
Bravo
AF:
0.0135
TwinsUK
AF:
0.00998
AC:
37
ALSPAC
AF:
0.00934
AC:
36
ESP6500AA
AF:
0.0103
AC:
43
ESP6500EA
AF:
0.00971
AC:
82
ExAC
AF:
0.0181
AC:
2193

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

FREM1: BS1, BS2 -

Congenital diaphragmatic hernia Uncertain:1
Mar 03, 2015
Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

It is unclear whether these changes, alone or in aggregate, are contributing to the development of CDH in this family. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oculotrichoanal syndrome Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Benign
0.41
T;T
Eigen
Uncertain
0.43
Eigen_PC
Uncertain
0.37
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.89
D;.
M_CAP
Benign
0.051
D
MetaRNN
Benign
0.0072
T;T
MetaSVM
Benign
-0.50
T
MutationAssessor
Pathogenic
2.9
M;M
PhyloP100
4.7
PrimateAI
Uncertain
0.51
T
PROVEAN
Uncertain
-4.1
D;D
REVEL
Uncertain
0.34
Sift
Uncertain
0.017
D;D
Sift4G
Uncertain
0.012
D;D
Polyphen
1.0
D;D
Vest4
0.57
ClinPred
0.034
T
GERP RS
3.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.36
gMVP
0.71
Mutation Taster
=59/41
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.77
dbscSNV1_RF
Benign
0.58
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41298151; hg19: chr9-14842658; COSMIC: COSV66524407; API